A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers
Clinical trial NCT03576651 · COMPLETED
Trial details
- NCT number
- NCT03576651
- Sponsor
- JHL Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-24
- Primary completion
- 2018-09-17
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.